Table 1 Relationship between the expression of UNC5B and clinicopathologic factors in BC patients
From: PKC α regulates netrin-1/UNC5B-mediated survival pathway in bladder cancer
Factors | Group | UNC5B expression | X2 | P value | |
|---|---|---|---|---|---|
High(%) | Low(%) | ||||
Gender | Male | 52(43.3%) | 25(20.8%) | 0.029 | 0.162 |
female | 29(24.2%) | 14(11.7%) | |||
Age at surgery | <55 | 29(24.2%) | 18(15.0%) | 2.152 | 0.247 |
≥55 | 44(36.6%) | 29(24.2%) | |||
Histologic grade | G1 | 18(15.0%)) | 5(4.2%) | 7.537 | 0.032 |
G2 | 49(40.8%) | 15(12.5%) | |||
G3 | 17(14.2%) | 16(13.3%) | |||
PT Stage | T1 | 29(24.2%) | 6(5.0%) | 19.564 | 0.014 |
T2 | 23(19.2%) | 12(10.0%) | |||
T3 | 13(10.8%) | 12(10.0%) | |||
T4 | 6(5.0%) | 19(15.8%) | |||
Tumor size(mm) | <10 | 16(13.3%) | 5(4.2%) | 2.011 | 0.436 |
10-30 | 32(26.7%) | 24(20.0%) | |||
>30 | 18(15.0%) | 25(20.8%) | |||
Multiplicity | Unifocal | 28(23.3%) | 24(20.0%) | 1.593 | 0.312 |
Multifocal | 39(32.5%) | 29(24.2%) | |||
Recurrence | Yes | 39(32.5%) | 43(35.8%) | 31.573 | 0.220 |
No | 14(11.7%) | 24(20.0%) | |||
Metastasis | Yes | 7(5.8%) | 19(15.8%) | 13.253 | 0.001 |
No | 69(57.5%) | 25(20.9%) | |||